Biotech Division of Greenland Mines Announces Australian Patent Grant for Klotho Gene Therapy Technology for Treatment of Neuromuscular DiseasesNEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- via IBN -- Greenland Mines Ltd (Nasdaq: GRML) ("Greenland Mines" or the "Company") today announced that IP Australia has granted Australian Patent No. 2023252508, entitled "Treatment of Neuromuscular Diseases via Gene Therapy that Expresses Klotho Protein," covering technology exclusively licensed by the Company's Biotech Division. The patented technology was invented by researchers at Universitat Autònoma de Barcelona and collaborating institutions.
Greenland Mines Adds World Class Magmatic Researchers and Greenland Specialists to 2026 Skaergaard Field CampaignCHARLOTTE, N.C., July 07, 2026 (GLOBE NEWSWIRE) -- via IBN -- Greenland Mines Ltd (“Greenland Mines” or the “Company”) (Nasdaq: GRML) is pleased to announce that Professor Wolfgang Maier and Associate Professor Kristoffer Szilas will join the Company’s 2026 field campaign at the Skaergaard precious and critical metals project in southeast Greenland as part of the geological exploration and development team.
